A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...

Stimulants are classified by the Drug Enforcement Agency (DEA) as Schedule II drugs because they carry a high risk for misuse, abuse, and addiction. Children may be treated with a short-acting ...